N-of-1 randomized controlled trials: An opportunity for complementary and alternative medicine evaluation

Journal of Alternative and Complementary Medicine

Volumn 10, Issue 6, 2004, Pages 979-984

  Johnston, Bradley C ^a   Mills, Edward ^b,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CANADIAN COLLEGE OF NATUROPATHIC MEDICINE   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MEDICINE; BIOLOGICAL ACTIVITY; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICAL SIGNIFICANCE;

BIAS (EPIDEMIOLOGY); COMPLEMENTARY THERAPIES; EFFECT MODIFIERS (EPIDEMIOLOGY); EVIDENCE-BASED MEDICINE; FEASIBILITY STUDIES; HUMANS; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 13144254184     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2004.10.979     Document Type: Review

References (39)

1. Austin J. Why patients use alternative medicine. Results from a national survey. JAMA 1998;279:1548-1553.
2. Barlow DH, Hersen M. Single Case Experiment Designs: Strategies for Evaluating Change, 2nd ed. New York: Pergamon, 1984.
3. Baldry P. Superficial versus deep dry needling. Acupunct Med 2002;20:78-81.
4. Brody H. The lie that heals: The ethics of giving placebos. Ann Intern Med 1982;97:112-118.
5. Brody H. True or false: The placebo effect as seen in drug studies is definitive proof that the mind can bring about clinically relevant changes in the body. Adv Mind-Body Med 2000;16:13-16.
6. Edgington ES. Statistics in single case analysis. Prog Behav Modif 1984;16:83-119.
7. Ernst E, Pittler MH, Stevinson C, White A, eds. The Desktop Guide to Complementary and Alternative Medicine: An Evidence-Based Approach. Edinburgh: Mosby, 2001.
8. Ernst E, Resch KL. Concept of true and perceived placebo effects. BMJ 1995;311:551-553.
9. Gronblad M, Hupli M, Wennerstrand P, Jarvinen E, Lukinonaa A, Kouri JP, Karaharju ED. Intercorrelation and test-retest reliability of the Pain Disability Index (PDI) and the Oswestry Disability Questionnaire (ODQ) and their correlation with pain intensity in low back pain patients. Clin J Pain 1993;9:189-195.
10. Guyatt G, Haynes B, Jaeschke R, Cook D, Greenhalgh T, Mead M, Green L, Naylor CD, Wilson M, McAlister F, Richardson WS. Introduction: The philosophy of evidence-based medicine, In: Guyatt G, Rennie D, eds. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. Chicago: American Medical Association Press, 2002:3-11.
11. Guyatt GH, Jaeschke R, Roberts R. N-of-1 randomized clinical trials in pharmacoepidemiology. In: Strom B, ed. Pharmacoepidemiology, 3rd ed. Chicago: John Wiley & Sons Inc, 2000:615-631.
12. Guyatt GH, Keller JL, Jaeschke R, Rosenbloom D, Adachi JD, Newhouse MT. The n of 1 randomized controlled trial: Clinical usefulness. Our three-year experience. Ann Intern Med 1990;112:293-299.
13. Guyatt G, Sackett D, Adachi J, Roberts R, Chong J, Rosenbloom D, Keller J. A clinician's guide for conducting randomized trials in individual patients. CMAJ 1988;139:497-503.
14. Guyatt G, Sackett D, Taylor DW, Chong J, Roberts R, Pugsley S. Determining optimal therapy - Randomized trials in individual patients. N Engl J Med 1986;314:889-892.
15. Guyatt G, Straus S, McAlister F, Haynes B, Sinclair J, Devereaux PJ, Lacchetti C. Moving from evidence to action: Incorporating patient values, In: Guyatt G, Rennie D, eds. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. Chicago: American Medical Association Press, 2001:567-582.
16. Houpt JB, McMillan R, Wein C, Paget-Dellio SD. Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol 1999;11:2423-2430.
17. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001;344:1594-1602.
18. Irwig L, Glasziou P, March L. Ethics of n-of-1 trials. Lancet 1995;345:469.
19. Jaeschke R, Adachi J, Guyatt G, Keller J, Wong B. Clinical usefulness of amitriptyline in fibromyalgia: The results of 23 N of 1 randomized controlled trials. J Rheumatol 1991;18:447-451.
20. Joannessen T. Controlled trials in single subjects: Value in clinical medicine. BMJ 1991;303:173-174.
21. Karnon J, Qizilbash N. Economic evaluation alongside n-of-1 trials: Getting closer to the margin. Health Econ Lett 2001;10:79-82.
22. Kazdin AE. Single-Case Research Designs: Methods for Clinical and Applied Settings. New York: Oxford University Press, 1982.
23. Kratchowill TR. Single Subject Research: Strategies for Evaluating Change. New York: Academic Press, 1978.
24. Larson EB, Ellesworth AJ, Oas J. Randomized clinical trials in single patients during a 2-year period. JAMA 1993;270:2708-2712.
25. Lacchetti C, Guyatt G. Therapy and validity: Surprising results of randomized controlled trials, In: Guyatt G, Rennie D, eds. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. Chicago: American Medical Association Press, 2002:247-265.
26. Mahon J, Laupacis A, Donner A, Wood T. Randomized study of n-of-1 trials versus standard practice. BMJ 1996;312:1069-1074.
27. Mahon J, Laupacis A, Hodder, RV, McKim DA, Paterson NA, Wood TE, Donner A. Theophylline for irreversible chronic airflow limitation: A randomized study comparing n-of-1 trials to standard practice. Chest 1999;115:38-48.
28. McAlindon TE, LaValley MP, Felson DT. Efficacy of glucosamine and chondroitin for treatment of osteoarthritis JAMA 2000;284:1241.
29. McLeod RS, Taylor DW, Cohen Z, Cullen JB. Single-patient randomised clinical trial. Use in determining optimum treatment for patient with inflammation of Kock continent ileostomy reservoir. Lancet 1986;1:726-728.
30. Menard J, Serrurier D, Bautier P, Plouin PF, Corvol P. Crossover design to test antihypertensive drugs with self-recorded blood pressure. Hypertension 1988;11:153-159.
31. Montori VM, Guyatt GH. What is evidence-based medicine and why should it be practiced? Respir Care 2001;46:1201-1214.
32. Nahin RL, Straus SE. Research into complementary and alternative medicine: Problems and potential. BMJ 2001;322:161-164.
33. Peters D, ed. Understanding the Placebo Effect in Complementary Medicine: Theory, Practice and Research. Edinburgh: Mosby, 2001.
34. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanik ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Okene J, Writing Group for the Women's Health Initiative Investigation. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principle results from the women's health initiative. JAMA 2002;288:321-333.
35. Verhoef MJ, Casebeer AL, Hilsden RJ. Assessing efficacy of complementary medicine: Adding qualitative research methods to the "gold standard." J Altern Complement Med 2002;8:275-278.
36. Vogler BK, Pittler MH, Ernst E. Feverfew as a preventative treatment for migraine: A systematic review. Cephalalgia 1998;18:704-708.
37. Wilson K, McGowan J, Guyatt G, Mills E. Teaching evidence-based complementary and alternative medicine: 3. Asking the questions and identifying the information. J Altern Complement Med 2002b;8:499-506.
38. Wilson K, Mills E. Introducing evidence-based complementary and alternative medicine: Answering the challenge. J Altern Complment Med 2002a;8:103-105.
39. Wilson K, Mills E, Ross C, Guyatt G. Teaching evidence-based complementary and alternative medicine: 4. Appraising the evidence for papers on therapy. J Altern Complement Med 2002c; 8:673-679.